Role of Nasal Nitric Oxide in Primary Ciliary Dyskinesia and Other Respiratory Conditions in Children

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2023 Nov 25

PMID 38003348

Authors

Salvatore Paterno

Laura Pisani

Stefania Zanconato

Valentina Agnese Ferraro

Silvia Carraro

Affiliations

Soon will be listed here.

Abstract

Nitric oxide (NO) is produced within the airways and released with exhalation. Nasal NO (nNO) can be measured in a non-invasive way, with different devices and techniques according to the age and cooperation of the patients. Here, we conducted a narrative review of the literature to examine the relationship between nNO and some respiratory diseases with a particular focus on primary ciliary dyskinesia (PCD). A total of 115 papers were assessed, and 50 were eventually included in the review. nNO in PCD is low (below 77 nL/min), and its measurement has a clear diagnostic value when evaluated in a clinically suggestive phenotype. Many studies have evaluated the role of NO as a molecular mediator as well as the association between nNO values and genotype or ciliary function. As far as other respiratory diseases are concerned, nNO is low in chronic rhinosinusitis and cystic fibrosis, while increased values have been found in allergic rhinitis. Nonetheless, the role in the diagnosis and prognosis of these conditions has not been fully clarified.

Citing Articles

Convergence of autism proteins at the cilium.

Kostyanovskaya E, Lasser M, Wang B, Schmidt J, Bader E, Buteo C bioRxiv. 2024; .

PMID: 39677731 PMC: 11643032. DOI: 10.1101/2024.12.05.626924.

Delayed Diagnosis of Primary Ciliary Dyskinesia in Low-Middle-Income Countries: The Clinical Value of Nasal Nitric Oxide.

Ortiz-Farias D, Rodriguez-Guzman A, Cortes-Telles A, Figueroa-Hurtado E Cureus. 2024; 16(10):e71888.

PMID: 39564026 PMC: 11576054. DOI: 10.7759/cureus.71888.

Type 2 Biomarkers and Their Clinical Implications in Bronchiectasis: A Prospective Cohort Study.

Chen Y, Hou H, Chien N, Lu K, Chen Y, Hung Z Lung. 2024; 202(5):695-709.

PMID: 38884647 PMC: 11427600. DOI: 10.1007/s00408-024-00707-0.

Redox Imbalance in Nasal Epithelial Cells of Primary Ciliary Dyskinesia Patients.

Reula A, Castillo-Corullon S, Armengot M, Herrera G, Escribano A, Dasi F Antioxidants (Basel). 2024; 13(2).

PMID: 38397788 PMC: 10885940. DOI: 10.3390/antiox13020190.

References

Pifferi M, Boner A, Gracci S, Fonnesu R, Maj D, Donzelli G . Longitudinal Nitric Oxide Levels and Infections by Ultrastructure and Genotype in Primary Ciliary Dyskinesia. Chest. 2022; 162(6):1265-1276. DOI: 10.1016/j.chest.2022.06.019. View

Lundberg J, Weitzberg E, Nordvall S, Kuylenstierna R, Lundberg J, Alving K . Primarily nasal origin of exhaled nitric oxide and absence in Kartagener's syndrome. Eur Respir J. 1994; 7(8):1501-4. DOI: 10.1183/09031936.94.07081501. View

Pifferi M, Bush A, Mariani F, Piras M, Michelucci A, Cangiotti A . Lung Function Longitudinal Study by Phenotype and Genotype in Primary Ciliary Dyskinesia. Chest. 2020; 158(1):117-120. DOI: 10.1016/j.chest.2020.02.001. View

Marthin J, Nielsen K . Hand-held tidal breathing nasal nitric oxide measurement--a promising targeted case-finding tool for the diagnosis of primary ciliary dyskinesia. PLoS One. 2013; 8(2):e57262. PMC: 3577728. DOI: 10.1371/journal.pone.0057262. View

Legendre M, Thouvenin G, Taytard J, Baron M, Le Bourgeois M, Tamalet A . High Nasal Nitric Oxide, Cilia Analyses, and Genotypes in a Retrospective Cohort of Children with Primary Ciliary Dyskinesia. Ann Am Thorac Soc. 2022; 19(10):1704-1712. DOI: 10.1513/AnnalsATS.202110-1175OC. View

Kouis P, Hadjisavvas A, Middleton N, Papatheodorou S, Kyriacou K, Yiallouros P . The effect of l-Arginine on Ciliary Beat Frequency in PCD patients, non-PCD respiratory patients and healthy controls. Pulm Pharmacol Ther. 2017; 48:15-21. DOI: 10.1016/j.pupt.2017.10.010. View

Kirihene R, Rees G, Wormald P . The influence of the size of the maxillary sinus ostium on the nasal and sinus nitric oxide levels. Am J Rhinol. 2002; 16(5):261-4. View

Liu D, Huang Z, Huang Y, Yi X, Chen X . Measurement of nasal and fractional exhaled nitric oxide in children with upper airway inflammatory disease: Preliminary results. Int J Pediatr Otorhinolaryngol. 2015; 79(12):2308-11. DOI: 10.1016/j.ijporl.2015.10.033. View

Leigh M, Hazucha M, Chawla K, Baker B, Shapiro A, Brown D . Standardizing nasal nitric oxide measurement as a test for primary ciliary dyskinesia. Ann Am Thorac Soc. 2013; 10(6):574-81. PMC: 3960971. DOI: 10.1513/AnnalsATS.201305-110OC. View

10.

Lucas J, Walker W . NO way! Nasal nitric oxide measurement in infants. Eur Respir J. 2018; 51(6). DOI: 10.1183/13993003.00958-2018. View

11.

Yoshida K, Takabayashi T, Imoto Y, Sakashita M, Narita N, Fujieda S . Reduced nasal nitric oxide levels in patients with eosinophilic chronic rhinosinusitis. Allergol Int. 2018; 68(2):225-232. DOI: 10.1016/j.alit.2018.09.005. View

12.

Zahid M, Bais A, Tian X, Devine W, Lee D, Yau C . Airway ciliary dysfunction and respiratory symptoms in patients with transposition of the great arteries. PLoS One. 2018; 13(2):e0191605. PMC: 5812576. DOI: 10.1371/journal.pone.0191605. View

13.

OCallaghan C, Chilvers M, Hogg C, Bush A, Lucas J . Diagnosing primary ciliary dyskinesia. Thorax. 2007; 62(8):656-7. PMC: 2117265. DOI: 10.1136/thx.2007.083147. View

14.

Pifferi M, Bush A, Rizzo M, Tonacci A, Di Cicco M, Piras M . Olfactory dysfunction is worse in primary ciliary dyskinesia compared with other causes of chronic sinusitis in children. Thorax. 2018; 73(10):980-982. DOI: 10.1136/thoraxjnl-2017-210661. View

15.

. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med. 2005; 171(8):912-30. DOI: 10.1164/rccm.200406-710ST. View

16.

Maniscalco M, Sofia M, Pelaia G . Nitric oxide in upper airways inflammatory diseases. Inflamm Res. 2007; 56(2):58-69. DOI: 10.1007/s00011-006-6111-1. View

17.

Collins S, Gove K, Walker W, Lucas J . Nasal nitric oxide screening for primary ciliary dyskinesia: systematic review and meta-analysis. Eur Respir J. 2014; 44(6):1589-99. DOI: 10.1183/09031936.00088614. View

18.

Leigh M, Ferkol T, Davis S, Lee H, Rosenfeld M, Dell S . Clinical Features and Associated Likelihood of Primary Ciliary Dyskinesia in Children and Adolescents. Ann Am Thorac Soc. 2016; 13(8):1305-13. PMC: 5021075. DOI: 10.1513/AnnalsATS.201511-748OC. View

19.

Behan L, Dimitrov B, Kuehni C, Hogg C, Carroll M, Evans H . PICADAR: a diagnostic predictive tool for primary ciliary dyskinesia. Eur Respir J. 2016; 47(4):1103-12. PMC: 4819882. DOI: 10.1183/13993003.01551-2015. View

20.

Michl R, Hentschel J, Fischer C, Beck J, Mainz J . Reduced nasal nitric oxide production in cystic fibrosis patients with elevated systemic inflammation markers. PLoS One. 2013; 8(11):e79141. PMC: 3827333. DOI: 10.1371/journal.pone.0079141. View